Zoetis (ZTS) Other Working Capital Changes (2012 - 2026)
Zoetis' (ZTS) quarterly Other Working Capital Changes came in at $66.0 million in Q1 2026, up 43.48% year-on-year from $46.0 million in Q1 2025, and up 760.0% on a QoQ basis from -$10.0 million in Q4 2025.
Zoetis (ZTS) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Other Working Capital Changes data on file, last reported at $66.0 million in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 43.48% year-over-year to $66.0 million in Q1 2026; TTM through Mar 2026 was $185.0 million, a 1333.33% increase from a year earlier, with the FY2025 full-year figure at $165.0 million, up 417.31% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $66.0 million, up from -$10.0 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for ZTS reached as high as $116.0 million in Q2 2025 and fell as low as -$66.0 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged $14.1 million across 5 years, with a median of $13.0 million in 2025.
- Across the five-year window, Other Working Capital Changes plunged 466.67% in 2022 and soared 2300.0% in 2023, its largest moves.
- Year by year, Other Working Capital Changes stood at -$55.0 million in 2022, then jumped by 56.36% to -$24.0 million in 2023, then sank by 175.0% to -$66.0 million in 2024, then soared by 84.85% to -$10.0 million in 2025, then soared by 760.0% to $66.0 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $66.0 million in Q1 2026, -$10.0 million in Q4 2025, and $13.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -66.00 Mn |
| Dec 31, 2024 | -66.00 Mn |
| Dec 31, 2024 | -66.00 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Sep 30, 2024 | -21.00 Mn |